The prognosis for Chronic Lymphocytic Leukemia (CLL) varies based on several factors:

- Age: Older age often leads to a worse prognosis
- Gene Changes: Specific gene mutations can affect the outlook.
- Protein Levels: High levels of ZAP-70, CD38, or beta-2 microglobulin in the blood can indicate a worse prognosis.
- Show Full Answer

The prognosis for Chronic Lymphocytic Leukemia (CLL) varies based on several factors:

- Age: Older age often leads to a worse prognosis.
- Gene Changes: Specific gene mutations can affect the outlook.
- Protein Levels: High levels of ZAP-70, CD38, or beta-2 microglobulin in the blood can indicate a worse prognosis.
- Lymphocyte Growth: Quickly growing lymphocytes or high numbers of prolymphocytes can lead to a worse prognosis.

The CLL International Prognostic Index (CLL-IPI) is used to estimate prognosis, considering factors like age, CLL stage, and gene mutations. The risk groups are:

- Low-risk: 93.2% live at least five years.
- Intermediate-risk: 79.3% live at least five years.
- High-risk: 63.3% live at least five years.
- Very high-risk: 23.3% live at least five years.

For more personalized information, it's best to consult with a doctor.

 This AI-generated response comes from MyLeukemiaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Chronic Lymphocytic Leukemia Survival Rate and Outlook | MyLeukemiaTeam

What Is CLL? Prevalence, Prognosis, Treatment, and More | MyLeukemiaTeam